Blue Owl Capital Holdings LP Ultragenyx Pharmaceutical Inc. Transaction History
Blue Owl Capital Holdings LP
- $234 Million
- Q4 2024
A detailed history of Blue Owl Capital Holdings LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 118,238 shares of RARE stock, worth $4.57 Million. This represents 2.13% of its overall portfolio holdings.
Number of Shares
118,238
Previous 163,238
27.57%
Holding current value
$4.57 Million
Previous $9.07 Million
45.14%
% of portfolio
2.13%
Previous 2.99%
Shares
4 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
84.3MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$388 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$217 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$166 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$105 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$97.2 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.71B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...